Answers are grounded in this paper and cite their sources.
DCE US provides reproducible and sensitive assessment of vascular changes in response to antiangiogenic therapy. The disruption-replenishment infusion protocol is a flexible method suitable for many tumor types, but further studies are needed to assess whether this protocol may be predictive of patient outcome.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: